{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T05:03:01Z","timestamp":1746594181939},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,28]]},"DOI":"10.7759\/cureus.23567","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T13:57:25Z","timestamp":1648475845000},"source":"Crossref","is-referenced-by-count":1,"title":["Renin-Angiotensin Blockade Reduces Readmission for Acute Chest Syndrome in Sickle Cell Disease"],"prefix":"10.7759","author":[{"given":"Nneoma","family":"Wamkpah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuj","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Salzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahil","family":"Suman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Poisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostino","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422510","article-title":"The acute chest syndrome of sickle cell disease","volume":"342","author":"Platt OS","year":"2000","unstructured":"Platt OS. The acute chest syndrome of sickle cell disease. N Engl J Me. 2000, 342:1904-1907. 10.1056\/NEJM200006223422510","journal-title":"N Engl J Me"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn HF","year":"1997","unstructured":"Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997, 337:762-769. 10.1056\/NEJM199709113371107","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904013401307","article-title":"Management of sickle cell disease","volume":"340","author":"Steinberg MH","year":"1999","unstructured":"Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999, 340:1021-1030. 10.1056\/NEJM199904013401307","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804411","article-title":"Pulmonary complications of sickle cell disease","volume":"359","author":"Gladwin MT","year":"2008","unstructured":"Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med. 2008, 359:2254-2265. 10.1056\/NEJMra0804411","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0950-3536(05)80066-6","article-title":"Sickle cell disease pathophysiology","volume":"6","author":"Noguchi CT","year":"1993","unstructured":"Noguchi CT, Schechter AN, Rodgers GP. Sickle cell disease pathophysiology. Baillieres Clin Haematol. 1993, 6:57-91. 10.1016\/s0950-3536(05)80066-6","journal-title":"Baillieres Clin Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt OS","year":"1994","unstructured":"Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994, 330:1639-1644. 10.1056\/NEJM199406093302303","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group","volume":"342","author":"Vichinsky EP","year":"2000","unstructured":"Vichinsky EP, Neumayr LD, Earles AN, et al.. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000, 342:1855-1865. 10.1056\/NEJM200006223422502","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin MT","year":"2004","unstructured":"Gladwin MT, Sachdev V, Jison ML, et al.. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004, 350:886-895. 10.1056\/NEJMoa035477","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200147","article-title":"Patterns of mortality in sickle cell disease in adults in France and England","volume":"3","author":"Perronne V","year":"2002","unstructured":"Perronne V, Roberts-Harewood M, Bachir D, et al.. Patterns of mortality in sickle cell disease in adults in France and England. Hematol J. 2002, 3:56-60. 10.1038\/sj.thj.6200147","journal-title":"Hematol J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0885066617712676","article-title":"Integrating fat embolism syndrome scoring indices in sickle cell disease: a practice management review","volume":"34","author":"Bailey K","year":"2019","unstructured":"Bailey K, Wesley J, Adeyinka A, Pierre L. Integrating fat embolism syndrome scoring indices in sickle cell disease: a practice management review. J Intensive Care Med. 2019, 34:797-804. 10.1177\/0885066617712676","journal-title":"J Intensive Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.11.3107.3107","article-title":"Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia","volume":"83","author":"Vichinsky E","year":"1994","unstructured":"Vichinsky E, Williams R, Das M, et al.. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood. 1994, 83:3107-3112. 10.1182\/blood.V83.11.3107.3107","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3109\/01902149609074016","article-title":"Sequential appearance of inflammatory mediators in rat bronchoalveolar lavage fluid after oleic acid-induced lung injury","volume":"22","author":"Syrbu S","year":"1996","unstructured":"Syrbu S, Thrall RS, Smilowitz HM. Sequential appearance of inflammatory mediators in rat bronchoalveolar lavage fluid after oleic acid-induced lung injury. Exp Lung Res. 1996, 22:33-49. 10.3109\/01902149609074016","journal-title":"Exp Lung Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710303371808","article-title":"Case 34-1997 \u2014 A 22-year-old man with a sickle cell crisis and sudden death","volume":"337","author":"McMahon LEC","year":"1997","unstructured":"McMahon LEC, Mark EJ. Case 34-1997 \u2014 A 22-year-old man with a sickle cell crisis and sudden death. N Engl J Med. 1997, 337:1293-301. 10.1056\/NEJM199710303371808","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198312293092607","article-title":"Case 52-1983 \u2014 Pulmonary hypertension associated with abnormal hemoglobin","volume":"309","author":"Scully RE","year":"1983","unstructured":"Scully RE, Mark EJ, McNeely BU. Case 52-1983 \u2014 Pulmonary hypertension associated with abnormal hemoglobin. N Engl J Med. 1983, 309:1627-1636. 10.1056\/NEJM198312293092607","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02157-7","article-title":"Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia","volume":"355","author":"Gladwin MT","year":"2000","unstructured":"Gladwin MT, Rodgers GP. Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia. Lancet. 2000, 355:1476-1478. 10.1016\/S0140-6736(00)02157-7","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.6.2573.bloodjournal8762573","article-title":"Phospholipase A2 levels in acute chest syndrome of sickle cell disease","volume":"87","author":"Styles LA","year":"1996","unstructured":"Styles LA, Schalkwijk CG, Aarsman AJ, Vichinsky EP, Lubin BH, Kuypers FA. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood. 1996, 87:2573-2578. 10.1182\/blood.V87.6.2573.bloodjournal8762573","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.85178","article-title":"Fat embolism: what we have learned from animal models","author":"Poisner AM","year":"2019","unstructured":"Poisner AM, Molteni A. Fat embolism: what we have learned from animal models. Embolic disease - evolving diagnostic and management approaches. Stawicki SP, Firstenberg MS, Swaroop M (ed):  IntechOpen, 2019. 10.5772\/intechopen.85178"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.paf.0000257397.92466.50","article-title":"Sickle cell lung disease and sudden death: a retrospective\/prospective study of 21 autopsy cases and literature review","volume":"28","author":"Graham JK","year":"2007","unstructured":"Graham JK, Mosunjac M, Hanzlick RL, Mosunjac M. Sickle cell lung disease and sudden death: a retrospective\/prospective study of 21 autopsy cases and literature review. Am J Forensic Med Pathol. 2007, 28:168-172. 10.1097\/01.paf.0000257397.92466.50","journal-title":"Am J Forensic Med Pathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache S","year":"1995","unstructured":"Charache S, Terrin ML, Moore RD, et al.. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995, 332:1317-1322. 10.1056\/NEJM199505183322001","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2006.00239.x","article-title":"Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist","volume":"24","author":"Santos RA","year":"2006","unstructured":"Santos RA, Ferreira AJ. Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist. Cardiovasc Drug Rev. 2006, 24:239-246. 10.1111\/j.1527-3466.2006.00239.x","journal-title":"Cardiovasc Drug Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000001278","article-title":"The renin inhibitor aliskiren protects rat lungs from the histopathologic effects of fat embolism","volume":"82","author":"Fletcher AN","year":"2017","unstructured":"Fletcher AN, Molteni A, Ponnapureddy R, Patel C, Pluym M, Poisner AM. The renin inhibitor aliskiren protects rat lungs from the histopathologic effects of fat embolism. J Trauma Acute Care Surg. 2017, 82:338-344. 10.1097\/TA.0000000000001278","journal-title":"J Trauma Acute Care Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-147-38323","article-title":"The effect of chronic alveolar hypoxia on lung and serum angiotensin I converting enzyme activity","volume":"147","author":"Molteni A","year":"1974","unstructured":"Molteni A, Zakheim RM, Mullis KB, Mattioli L. The effect of chronic alveolar hypoxia on lung and serum angiotensin I converting enzyme activity. Proc Soc Exp Biol Med. 1974, 147:263-265. 10.3181\/00379727-147-38323","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(75)80081-3","article-title":"Angiotensin-I-converting enzyme activity in idiopathic respiratory distress syndrome of the newborn infant and in experimental alveolar hypoxia in mice","volume":"87","author":"Mattioli L","year":"1975","unstructured":"Mattioli L, Zakheim RM, Mullis K, Molteni A. Angiotensin-I-converting enzyme activity in idiopathic respiratory distress syndrome of the newborn infant and in experimental alveolar hypoxia in mice. J Pediatr. 1975, 87:97-101. 10.1016\/s0022-3476(75)80081-3","journal-title":"J Pediatr"},{"key":"ref24","article-title":"Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat","volume":"33","author":"Zakheim RM","year":"1975","unstructured":"Zakheim RM, Mattioli L, Molteni A, Mullis KB, Bartley J. Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat. Lab Invest. 1975, 33:57-61.","journal-title":"Lab Invest"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1976.41.4.462","article-title":"Plasma angiotensin II levels in hypoxic and hypovolemic stress in unanesthetized rabbits","volume":"41","author":"Zakheim RM","year":"1976","unstructured":"Zakheim RM, Molteni A, Mattioli L, Park M. Plasma angiotensin II levels in hypoxic and hypovolemic stress in unanesthetized rabbits. J Appl Physiol. 1976, 41:462-465. 10.1152\/jappl.1976.41.4.462","journal-title":"J Appl Physiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e3181e50df6","article-title":"Mitigating effects of captopril and losartan on lung histopathology in a rat model of fat embolism","volume":"70","author":"McIff TE","year":"2011","unstructured":"McIff TE, Poisner AM, Herndon B, Lankachandra K, Molteni A, Adler F. Mitigating effects of captopril and losartan on lung histopathology in a rat model of fat embolism. J Trauma. 2011, 70:1186-1191. 10.1097\/TA.0b013e3181e50df6","journal-title":"J Trauma"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e31823c96b0","article-title":"Persistent and progressive pulmonary fibrotic changes in a model of fat embolism","volume":"72","author":"Poisner AM","year":"2012","unstructured":"Poisner AM, Adler F, Uhal B, et al.. Persistent and progressive pulmonary fibrotic changes in a model of fat embolism. J Trauma Acute Care Surg. 2012, 72:992-998. 10.1097\/TA.0b013e31823c96b0","journal-title":"J Trauma Acute Care Surg"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.221292098","article-title":"Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease","volume":"98","author":"Aslan M","year":"2001","unstructured":"Aslan M, Ryan TM, Adler B, et al.. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci U S A. 2001, 98:15215-15220. 10.1073\/pnas.221292098","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-3218fje","article-title":"Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice","volume":"19","author":"Wood KC","year":"2005","unstructured":"Wood KC, Hebbel RP, Granger DN. Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice. FASEB J. 2005, 19:989-991. 10.1096\/fj.04-3218fje","journal-title":"FASEB J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-039438","article-title":"Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability","volume":"109","author":"Hsu LL","year":"2007","unstructured":"Hsu LL, Champion HC, Campbell-Lee SA, et al.. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood. 2007, 109:3088-3098. 10.1182\/blood-2006-08-039438","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4322\/acr.2017.043","article-title":"Bone marrow necrosis and fat embolism syndrome: a dreadful complication of hemoglobin sickle cell disease","volume":"7","author":"Targueta EP","year":"2017","unstructured":"Targueta EP, Hirano AC, de Campos FP, Martines JA, Lovisolo SM, Felipe-Silva A. Bone marrow necrosis and fat embolism syndrome: a dreadful complication of hemoglobin sickle cell disease. Autops Case Rep. 2017, 7:42-50. 10.4322\/acr.2017.043","journal-title":"Autops Case Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(96)91378-1","article-title":"Hydroxyurea reacts with heme proteins to generate nitric oxide","volume":"347","author":"Pacelli R","year":"1996","unstructured":"Pacelli R, Taira J, Cook JA, Wink DA, Krishna MC. Hydroxyurea reacts with heme proteins to generate nitric oxide. Lancet. 1996, 347:900. 10.1016\/s0140-6736(96)91378-1","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1124\/mol.55.6.1006","article-title":"Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea","volume":"55","author":"Glover RE","year":"1999","unstructured":"Glover RE, Ivy ED, Orringer EP, Maeda H, Mason RP. Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea. Mol Pharmacol. 1999, 55:1006-1010. 10.1124\/mol.55.6.1006","journal-title":"Mol Pharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.7.2554","article-title":"Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea","volume":"89","author":"Styles LA","year":"1997","unstructured":"Styles LA, Lubin B, Vichinsky E, et al.. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood. 1997, 89:2554-2559. 10.1182\/blood.V89.7.2554","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1159\/000040964","article-title":"Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy","volume":"102","author":"Saleh AW","year":"1999","unstructured":"Saleh AW, Hillen HF, Duits AJ. Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy. Acta Haematol. 1999, 102:31-37. 10.1159\/000040964","journal-title":"Acta Haematol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga KI","year":"2017","unstructured":"Ataga KI, Kutlar A, Kanter J, et al.. Crizanlizumab for the prevention of pain crises in sickle cell disease. N Engl J Med. 2017, 376:429-439. 10.1056\/NEJMoa1611770","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara Y","year":"2018","unstructured":"Niihara Y, Miller ST, Kanter J, et al.. A phase 3 trial of l-glutamine in sickle cell disease. N Engl J Med. 2018, 379:226-235. 10.1056\/NEJMoa1715971","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8652(199806)58:2<117::aid-ajh5>3.0.co;2-v","article-title":"Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential","volume":"58","author":"Niihara Y","year":"1998","unstructured":"Niihara Y, Zerez CR, Akiyama DS, Tanaka KR. Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential. Am J Hematol. 1998, 58:117-121. 10.1002\/(sici)1096-8652(199806)58:2&lt;117::aid-ajh5&gt;3.0.co;2-v","journal-title":"Am J Hematol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehpc.2017.03.002","article-title":"Fatal unsuspected fat embolism syndrome in a sickle cell patient","volume":"8","author":"Shyu S","year":"2017","unstructured":"Shyu S, Rubin M. Fatal unsuspected fat embolism syndrome in a sickle cell patient. Hum Pathol. 2017, 8:62-64. 10.1016\/j.ehpc.2017.03.002","journal-title":"Hum Pathol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1080\/01902148.2018.1552339","article-title":"Evidence for angiotensin mediation of the late histopathological effects of pulmonary fat embolism: protection by losartan in a rat model","volume":"44","author":"Poisner A","year":"2018","unstructured":"Poisner A, Bass D, Fletcher A, et al.. Evidence for angiotensin mediation of the late histopathological effects of pulmonary fat embolism: protection by losartan in a rat model. Exp Lung Res. 2018, 44:361-367. 10.1080\/01902148.2018.1552339","journal-title":"Exp Lung Res"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1394153","article-title":"Nontraumatic fat embolism found following maternal death after cesarean delivery","volume":"5","author":"Schrufer-Poland T","year":"2015","unstructured":"Schrufer-Poland T, Singh P, Jodicke C, Reynolds S, Maulik D. Nontraumatic fat embolism found following maternal death after cesarean delivery. AJP Rep. 2015, 5:e1-e5. 10.1055\/s-0034-1394153","journal-title":"AJP Rep"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.5430\/crcp.v2n3p30","article-title":"Fat embolism syndrome following caesarean section in an obese patient and its histopathological similarity to an animal model of FE: a case report","volume":"2","author":"Ajemba O","year":"2015","unstructured":"Ajemba O, Zia H, Lankachandra K, Singh G, Poisner A, Herndon B, Molteni A. Fat embolism syndrome following caesarean section in an obese patient and its histopathological similarity to an animal model of FE: a case report. CRCP. 2015, 2:30-35. 10.5430\/crcp.v2n3p30","journal-title":"CRCP"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2017.12.002","article-title":"Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases","volume":"40","author":"Tan WS","year":"2018","unstructured":"Tan WS, Liao W, Zhou S, Mei D, Wong WF. Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases. Curr Opin Pharmacol. 2018, 40:9-17. 10.1016\/j.coph.2017.12.002","journal-title":"Curr Opin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/84242-renin-angiotensin-blockade-reduces-readmission-for-acute-chest-syndrome-in-sickle-cell-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:20Z","timestamp":1707507800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/84242-renin-angiotensin-blockade-reduces-readmission-for-acute-chest-syndrome-in-sickle-cell-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.23567","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,28]]}}}